The Impact of Drug Pooling on Clinical Supply Chain Processes


Our client was looking to understand supply chain processes for drug pooling in clinical trials.


The objective was to identify the cost, capabilities, and technologies necessary to successfully incorporate drug pooling into a pharmaceutical clinical supply chain process.

Our Work

10EQS identified experts from big pharmaceutical and contract research organizations to help our client define the overall outlook on drug pooling. The interviews explored the required capabilities and materials suited for drug pooling, use cases, as well as geographic, regulatory, and operational considerations influencing a pooling strategy. 

Project Team
  • 10EQS Delivery Operations (=PMO) providing quality assurance, process management and expert recruitment
  • 3 industry experts
Industry Experts
  • Clinical Supply Chain Manager – Biotechnology Company (US)
  • Senior Director, and Head Of Clinical Systems –Pharmaceutical Company (US)
  • Director & Principal Scientist – Pharmaceutical Company 


The client was provided with forward-looking insights including specific value-adds, developments, and recent innovations for drug pooling within the clinical supply chain process.